NEWS & UPDATES

Cannovation is pleased to announce the new changes within our organization as of January 1, 2025. We have created 3 clinical research...

1. Introduction to Psychedelic Medicine Psychedelic Medicine involves the use of psychedelic substances to treat various mental health...

Exploring the world of controlled substance research can seem daunting, especially with the complexities surrounding DEA Schedule 1...

In the ever-evolving world of drug development, NIH cannabis research is pushing boundaries like never before. Discover how this...

Introduction to the Future of Health and Cannabis The future of health is taking an exciting turn, and at the heart of this...

In the rapidly evolving world of medical cannabis, bringing new therapies from concept to market requires more than just a brilliant idea...

In the constantly evolving landscape of medical research, the National Institutes of Health (NIH) guidelines on cannabis are paving new...

At the intersection of science and society’s evolving perspectives, cannabinoid drug development represents a new frontier in medicine....

In an era where the opioid crisis has cast a long, ominous shadow over the realm of pain management, a beacon of hope emerges from an...

3Ever wondered about the science behind medical cannabis? Here’s how you can be a part of groundbreaking cannabis clinical trials!...

Introduction to Cannabis Research in the United States Research on cannabis in the United States has been a tough road, crowded with...

Introduction to the rescheduling of cannabis The change of cannabis to schedule 3 in the controlled substances list is a big deal....

[Atlanta, GA, April 19, 2024] – Cannovation Clinical Research Partners, a pioneering Cannabis-Based Clinical Research Organization for...